Terry Gregg is the CEO of DexCom, Inc., a company that specializes in continuous glucose monitoring technology. He has been with DexCom since 2015 and has over two decades of experience in the medical technology field. Before joining DexCom, Terry...

Terry Gregg is the CEO of DexCom, Inc., a company that specializes in continuous glucose monitoring technology. He has been with DexCom since 2015 and has over two decades of experience in the medical technology field. Before joining DexCom, Terry served as the President and COO of MiniMed, a company known for its insulin pumps, which was acquired by Medtronic. His deep background in diabetes care and medical devices drives his vision at DexCom. In 2023, he earned a total compensation of over $15 million, primarily through stock awards that demonstrate the company's strong financial performance. He has been involved in significant insider trading activities, with his holdings fluctuating impressively, indicating a strong belief in the company's future. Additionally, Terry has a history of leadership in organizations like the American Diabetes Association, showing his commitment to improving diabetes care. He holds a degree in Zoology from Colorado State University, which enhances his scientific approach to business in healthcare.